HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CCI 103F

hexafluorinated nitroimidazole; hypoxic cell marker; structure given in first source
Also Known As:
1-((1,1,1,3,3,3-Hexafluoropropan-2-yl)oxy)-3-(2-nitro-1H-imidazol-1-yl)propan-2; 1-(1,1,1,3,3,3-hexafluoropropan-2-yloxy)-3-(2-nitroimidazol-1-yl)propan-2-ol; CCI-103F
Networked: 19 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Raleigh, James A: 4 articles (09/2013 - 12/2002)
2. van der Kogel, Albert J: 4 articles (09/2013 - 07/2005)
3. Bussink, Johan: 4 articles (02/2007 - 09/2004)
4. Kaanders, Johannes H A M: 3 articles (02/2007 - 07/2005)
5. Ljungkvist, Anna S E: 3 articles (02/2007 - 07/2005)
6. Ashcroft, Margaret: 1 article (09/2013)
7. Baker, Lauren C J: 1 article (09/2013)
8. Boult, Jessica K R: 1 article (09/2013)
9. Burrell, Jake S: 1 article (09/2013)
10. Gilmour, Lesley D: 1 article (09/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Hypoxia (Hypoxemia)
3. Prolactinoma (Prolactinomas)
4. Sarcoma (Soft Tissue Sarcoma)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. pimonidazole
2. Nitroimidazoles
3. azomycin
4. Misonidazole
5. Paraffin
6. Oxygen (Dioxygen)
7. Niacinamide (Nicotinamide)
8. Peroxidase (Myeloperoxidase)
9. Immunosorbents
10. Formaldehyde (Formol)

Related Therapies and Procedures

1. Aftercare (After-Treatment)
2. Radiotherapy
3. Injections